Financials

  • Market Capitalization 12.96 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4697
NRSN
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.44 USD+4.76%+12.82%+12.82%-58.10%14.33 M USD
4701
ICU
SeaStar Medical Holding Corporation - Common Stock
3.14 USD+1.62%-4.27%-3.09%+27.64%13.84 M USD
4708
GTBP
GT Biopharma, Inc. - Common Stock
0.29 USD-3.33%-6.45%0.00%-68.82%13.08 M USD
4713
MBRX
Moleculin Biotech, Inc. - Common Stock
0.64 USD-1.54%+6.67%+72.97%-79.68%12.47 M USD

Notizie